Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic registry between 2013 and 2019

Autor: Lisa G. Spencer, Maria Loughenbury, Nazia Chaudhuri, Monica Spiteri, Helen Parfrey, BTS ILD Registry, Christine Fiddler, Gareth Walters, Sherwood Burge, Melanie Caswell, Simon Hart, Mark Major, David Adeboyeku, Ananthakrishnan Raghuram, Ling-Pei Ho, Arvind Rajasekaran, Aravind Ponnuswamy, Stephen Cowie, Mamoun Ibrahim, Christine O'Brien, Jane Scullion, Andrew White, Henry Steer, Dimitrina Petkova, Surinder Birring, Boris Lams, Robina Coker, Robert Buttery, Hannah Fletcher, John Hutchinson, Emad Hilal, Janet Fallon, Ahmed Fahim, Andrew Wilson, Georgina Hands, Alison Moody, Stephen Bianchi, Bhagyashree Jayaraman, Arnab Datta, William Chang, Jonathan Naylor, K. Suresh Babu, Robert Allcock, Philip Molyneaux, Srividya Narayan, Michael Gibbons, Katie Ward, Timothy Gatheral, Claire Squires, Ian Forrest, Mazhar Chaudri, Salman Ghani, Katherine Spinks, Huzaifa Adamali, Paul Beirne, Melissa Wickremasinghe, Joanna Porter, Beatriz Lara, Graham Miller, Sarah Haney, Laura MacKay, Steve O'Hickey, Owen Dempsey, Matthew Embley, George Chalmers, Sarah Davies, Ben Hope-Gill, Neil McAndrew, Paul Minnis, Karol Henry

Publikováno v: ERJ Open Research, Vol 7, Iss 1 (2021)

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and terminal interstitial lung disease (ILD) with a median survival of 3–5 years. The British Thoracic Society (BTS) established the UK IPF Registry in 2013 as a platform to collect data

Externí odkaz: https://doaj.org/article/5ce733f7aa814dbf8ec35344c7906172

P022 Audit of vitamin D and calcium level monitoring in sarcoidosis patients taking calcium and/or vitamin D supplements

Autor: Shannon Gunawardana, Deepak Nagra, Katie Bechman, Surinder Birring, James Galloway, Amit Patel

Publikováno v: Rheumatology. 61

Background/Aims Sarcoidosis is a chronic inflammatory disorder, for which steroids are a common treatment. A side effect of long-term steroid therapy is an increased risk of osteoporosis, and calcium and/or vitamin D supplementation may be indicated.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4a345fb406fbc5e8a7536ab5eaa27145
https://doi.org/10.1093/rheumatology/keac133.021

Idiopathic pulmonary fibrosis in the UK: analysis of the British Thoracic Society electronic registry between 2013 and 2019

Autor: Lisa G. Spencer, Maria Loughenbury, Nazia Chaudhuri, Monica Spiteri, Helen Parfrey, BTS ILD Registry, Christine Fiddler, Gareth Walters, Sherwood Burge, Melanie Caswell, Simon Hart, Mark Major, David Adeboyeku, Ananthakrishnan Raghuram, Ling-Pei Ho, Arvind Rajasekaran, Aravind Ponnuswamy, Stephen Cowie, Mamoun Ibrahim, Christine O'Brien, Jane Scullion, Andrew White, Henry Steer, Dimitrina Petkova, Surinder Birring, Boris Lams, Robina Coker, Robert Buttery, Hannah Fletcher, John Hutchinson, Emad Hilal, Janet Fallon, Ahmed Fahim, Andrew Wilson, Georgina Hands, Alison Moody, Stephen Bianchi, Bhagyashree Jayaraman, Arnab Datta, William Chang, Jonathan Naylor, K. Suresh Babu, Robert Allcock, Philip Molyneaux, Srividya Narayan, Michael Gibbons, Katie Ward, Timothy Gatheral, Claire Squires, Ian Forrest, Mazhar Chaudri, Salman Ghani, Katherine Spinks, Huzaifa Adamali, Paul Beirne, Melissa Wickremasinghe, Joanna Porter, Beatriz Lara, Graham Miller, Sarah Haney, Laura MacKay, Steve O'Hickey, Owen Dempsey, Matthew Embley, George Chalmers, Sarah Davies, Ben Hope-Gill, Neil McAndrew, Paul Minnis, Karol Henry

Publikováno v: ERJ Open Research
article-version (VoR) Version of Record
Spencer, L G, Loughenbury, M, Chaudhuri, N, Spiteri, M & Parfrey, H 2021, ' Idiopathic pulmonary fibrosis in the UK : analysis of the British Thoracic Society electronic registry between 2013 and 2019 ', ERJ Open Research, vol. 7, no. 1, pp. 00187-2020 . https://doi.org/10.1183/23120541.00187-2020
ERJ Open Research, Vol 7, Iss 1 (2021)

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and terminal interstitial lung disease (ILD) with a median survival of 3–5 years. The British Thoracic Society (BTS) established the UK IPF Registry in 2013 as a platform to collect data

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e3c9a8765b8ebc234eac1c6d6b6f761
https://pubmed.ncbi.nlm.nih.gov/33532476

Inhibition of P2X3 by MK-7264 reduces 24-hour cough frequency in a randomized, controlled, Phase 2b clinical trial

Autor: Michael M. Kitt, Surinder Birring, Alyn H. Morice, Jaclyn A. Smith, Lorcan McGarvey, Mandel R. Sher, Anthony P. Ford

Publikováno v: Clinical Problems Others.

Introduction: MK-7264 (formerly AF-219) is a P2X3 receptor antagonist that has been shown to reduce cough frequency in patients with chronic cough. Methods: This 12-week, double-blind, parallel group study conducted at 46 sites in the US and UK rando

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::94e201dd24cb4fb8ea5c21174d1c0b81
https://doi.org/10.1183/1393003.congress-2017.oa2932

Piloting and validating an innovation to triage patients presenting with cough to community pharmacies in Western Australia

Autor: Moyez, Jiwa, Jeff, Hughes, Deepa, Sriram, Surinder, Birring, Xingqiong, Meng, Gia, Cecchele, John, Cooke, Nicolas, Ng

Publikováno v: Quality in primary care. 20(2)

To develop a tool to assist community pharmacists to triage patients presenting with cough and to validate this against an established cough-specific quality of life (QoL) measure.A decision-support tool, the Pharmacy Cough Assessment Tool (PCAT) was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::79ca2d8ab3cca6e51ac5bb96ee9c4014
https://pubmed.ncbi.nlm.nih.gov/22824561